
Tenofovir Bel Tablets (Tenofovir Disoproxil Aspartate)
308.04mg
Tablet · Prescription medication
Jonggeun Pharmaceutical Co., Ltd.
Tenofovir disoproxil aspartate is an antiviral agent used in the treatment of chronic hepatitis B and HIV.
MFDS ingredient code M266022
Tenofovir disoproxil aspartate is a nucleotide analogue antiviral agent used in the treatment of chronic hepatitis B and HIV infection. This ingredient works by inhibiting the replication of the virus, thereby slowing the progression of the infection.
This ingredient prevents the virus from replicating its genetic material by interfering with the enzymes necessary for viral replication. This reduces the viral load in the body and helps inhibit the spread of infection.
Approved uses differ by product. Check each product's information for its actual use.
Tenofovir disoproxil aspartate has a lower risk of hepatotoxicity compared to other nucleotide analogues and is widely used in the treatment of chronic hepatitis B and HIV due to its high convenience of administration.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.